
Celestica (CLS) currently holds an average brokerage recommendation (ABR) of 1.50, signaling a 'Buy' equivalent from sell-side analysts. However, the article cautions against sole reliance on ABRs due to their inherent positive bias, instead advocating for the Zacks Rank, a quantitative model based on earnings estimate revisions. Notably, CLS's current year EPS estimate recently increased by 0.4% to $5.07, leading to a Zacks Rank #2 (Buy), which is presented as a more robust indicator for potential near-term stock appreciation.
Celestica (CLS) exhibits a strong bullish consensus from sell-side analysts, with an Average Brokerage Recommendation (ABR) of 1.50 on a 1-to-5 scale. This rating is derived from 12 brokerage firms, where ten of the twelve recommendations are either 'Strong Buy' (66.7%) or 'Buy' (16.7%). While this indicates significant optimism, the primary analysis suggests that a more reliable indicator for near-term performance is the trend in earnings estimate revisions. Supporting this view, the Zacks Consensus Estimate for Celestica's current-year EPS has recently increased by 0.4% to $5.07 over the past month. This positive revision, reflecting growing analyst optimism about the company's earnings prospects, has directly contributed to the stock achieving a Zacks Rank #2 (Buy), which corroborates the positive sentiment from the ABR with a quantitative, earnings-focused metric.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment